These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 31652599)

  • 1. Additional Evidence on Serological Correlates of Protection against Measles: An Observational Cohort Study among Once Vaccinated Children Exposed to Measles.
    Woudenberg T; van Binnendijk R; Veldhuijzen I; Woonink F; Ruijs H; van der Klis F; Kerkhof J; de Melker H; de Swart R; Hahné S
    Vaccines (Basel); 2019 Oct; 7(4):. PubMed ID: 31652599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Measles Virus-Based Vaccine Candidate Mediates Protection against Zika Virus in an Allogeneic Mouse Pregnancy Model.
    Nürnberger C; Bodmer BS; Fiedler AH; Gabriel G; Mühlebach MD
    J Virol; 2019 Feb; 93(3):. PubMed ID: 30429338
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Measles Outbreak Among Previously Immunized Healthcare Workers, the Netherlands, 2014.
    Hahné SJ; Nic Lochlainn LM; van Burgel ND; Kerkhof J; Sane J; Yap KB; van Binnendijk RS
    J Infect Dis; 2016 Dec; 214(12):1980-1986. PubMed ID: 27923955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measles Virus Hemagglutinin epitopes immunogenic in natural infection and vaccination are targeted by broad or genotype-specific neutralizing monoclonal antibodies.
    Muñoz-Alía MA; Casasnovas JM; Celma ML; Carabaña J; Liton PB; Fernandez-Muñoz R
    Virus Res; 2017 May; 236():30-43. PubMed ID: 28465158
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of serological and virological tests in the diagnosis of clinical and subclinical measles virus infections during an outbreak of measles in The Netherlands.
    van Binnendijk RS; van den Hof S; van den Kerkhof H; Kohl RH; Woonink F; Berbers GA; Conyn-van Spaendonck MA; Kimman TG
    J Infect Dis; 2003 Sep; 188(6):898-903. PubMed ID: 12964122
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa.
    Whittle HC; Aaby P; Samb B; Jensen H; Bennett J; Simondon F
    Lancet; 1999 Jan; 353(9147):98-102. PubMed ID: 10023894
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and Safety of an Intravenous Immune Globulin (IVIG) Preparation in Post-exposure Prophylaxis (PEP) Against Measles in Infants.
    Kohlmaier B; Holzmann H; Stiasny K; Leitner M; Zurl C; Strenger V; Kundi M; Zenz W
    Front Pediatr; 2021; 9():762793. PubMed ID: 34926346
    [No Abstract]   [Full Text] [Related]  

  • 8. Is early measles vaccination better than later measles vaccination?
    Aaby P; Martins CL; Ravn H; Rodrigues A; Whittle HC; Benn CS
    Trans R Soc Trop Med Hyg; 2015 Jan; 109(1):16-28. PubMed ID: 25573106
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune response after primary and re-vaccination with different combined vaccines against measles, mumps, rubella.
    Tischer A; Gerike E
    Vaccine; 2000 Jan; 18(14):1382-92. PubMed ID: 10618536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar Antibody Levels in 3-Year-Old Children Vaccinated Against Measles, Mumps, and Rubella at the Age of 12 Months or 18 Months.
    Kontio M; Palmu AA; Syrjänen RK; Lahdenkari M; Ruokokoski E; Davidkin I; Vaarala O; Melin M
    J Infect Dis; 2016 Jun; 213(12):2005-13. PubMed ID: 26908733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolation of measles virus from a naturally-immune, asymptomatically re-infected individual.
    Vardas E; Kreis S
    J Clin Virol; 1999 Aug; 13(3):173-9. PubMed ID: 10443793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Seroconversion of children following natural measles infection and vaccination.
    Odoemele CF; Ukwandu NC; Adu FD; Nmorsi OP; Anyanwu LC; Odike MA; Omotade OO
    J Pak Med Assoc; 2008 Sep; 58(9):501-5. PubMed ID: 18846800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serologic status and measles attack rates among vaccinated and unvaccinated children in rural Senegal.
    Samb B; Aaby P; Whittle HC; Seck AM; Rahman S; Bennett J; Markowitz L; Simondon F
    Pediatr Infect Dis J; 1995 Mar; 14(3):203-9. PubMed ID: 7761185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody persistence following on different vaccination strategies of domestic measles, mumps and rubella combined attenuated live vaccine: a 3-year follow-up study].
    He HQ; Li Q; Yan R; Zhou Y; Tang XW; Deng X; Xie SY; Chen ZP
    Zhonghua Yu Fang Yi Xue Za Zhi; 2017 Apr; 51(4):336-340. PubMed ID: 28395468
    [No Abstract]   [Full Text] [Related]  

  • 15. Application of a fast and cost-effective 'three-in-one' MMR ELISA as a tool for surveying anti-MMR humoral immunity: the Hungarian experience.
    Böröcz K; Csizmadia Z; Markovics Á; Farkas N; Najbauer J; Berki T; Németh P
    Epidemiol Infect; 2020 Feb; 148():e17. PubMed ID: 32014073
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Depletion of measles virus glycoprotein-specific antibodies from human sera reveals genotype-specific neutralizing antibodies.
    de Swart RL; Yüksel S; Langerijs CN; Muller CP; Osterhaus ADME
    J Gen Virol; 2009 Dec; 90(Pt 12):2982-2989. PubMed ID: 19710253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A serological survey of measles, mumps and rubella immunity among school aged children in Western Saudi Arabia.
    Jaber SM
    Saudi Med J; 2006 Jan; 27(1):63-9. PubMed ID: 16432596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of human immunodeficiency virus-1 infection and stunting on measles immunoglobulin-G levels in children vaccinated against measles in Uganda.
    Waibale P; Bowlin SJ; Mortimer EA; Whalen C
    Int J Epidemiol; 1999 Apr; 28(2):341-6. PubMed ID: 10342701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of neutralizing antibody titers against outbreak-associated measles genotypes (D4, H1 and B3) in Iran.
    Fatemi Nasab GS; Salimi V; Abbasi S; Adjami Nezhad Fard F; Mokhtari Azad T
    Pathog Dis; 2016 Nov; 74(8):. PubMed ID: 27777263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mumps-specific cross-neutralization by MMR vaccine-induced antibodies predicts protection against mumps virus infection.
    Gouma S; Ten Hulscher HI; Schurink-van 't Klooster TM; de Melker HE; Boland GJ; Kaaijk P; van Els CACM; Koopmans MPG; van Binnendijk RS
    Vaccine; 2016 Jul; 34(35):4166-4171. PubMed ID: 27372154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.